The approval of Casgevy, Vertex Pharmaceuticals Inc. and Crispr Therapeutics Inc.’s gene therapy for sickle cell disease, is a transformative moment in medicine. Not only is it the first Crispr-based drug to reach the market it’s a potentially life-altering advance for a patient population that has been for too long ignored and underserved by the medical establishment. Lyfgenia, a second gene therapy f.
FDA approves two new gene therapies for sickle cell disease, a functional cure for many patients mymoinfo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mymoinfo.com Daily Mail and Mail on Sunday newspapers.
FDA approves two sickle cell therapies, including the first CRISPR medicine washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.